Skip to main content

Share repurchase programme: Transactions of week 3 2026

The share repurchase programme runs as from 26 February 2025 and up to and including 30 January 2026 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 2.25 billion, cf. Corporate Announcement No. 3/2025 of 26 February 2025. The share repurchase programme is initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called “Market Abuse Regulation”, and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions have been made under the program:  Number of shares Average purchase price (DKK) Transaction value (DKK)Accumulated, previous announcement 3,130,478 665.93 2,084,679,51712 January 2026 14,000 871.00 12,193,94013 January...

Continue reading

WENDEL: Wendel Investment Managers affiliates successfully raised over €11 billion in European Private Equity & US Private Credit Markets

 Wendel Investment Managers affiliates successfully raised over €11 billion in European Private Equity & US Private Credit Markets IK Partners, a leading European private equity firm that joined Wendel in October 2023 and Monroe Capital, a leading US private credit investment firm that joined Wendel in October 2024, have raised more than €11 billion in aggregate in their closed end funds since joining Wendel Investment Managers. This outstanding fundraising performance demonstrates the strong attractivity of Wendel Investment Managers platform. Following the acquisition of Committed Advisors announced in October 2025, WIM will manage more than €46 billion in assets (AuM) in three private asset classes: private equity, private debt, and secondary markets and is expected to generate annual FRE0F1 in excess of €2001F2 million in 2026...

Continue reading

4/2026・Trifork Group: Weekly report on share buyback

Schindellegi, Switzerland – 19 January 2026 Trifork Group AGCompany announcement no. 4/2026 Weekly report on share buyback On 22 December 2025, Trifork initiated a share buyback program in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buyback program runs from 23 December 2025 up to and including no later than 26 February 2026. For details, please see company announcement no. 58 of 22 December 2025. Under the share buyback program, Trifork will purchase shares for up to a total of DKK 14.92 million (approximately EUR 2 million). Prior to the launch of the share buyback, Trifork held 219,735 treasury shares, corresponding to 1.1% of the share capital. Under the program, the following transactions...

Continue reading

Major Shareholders Significantly Increase Stakes in Tonner Drones: Confirmation of Confidence in Turnaround and Growth Strategy

Major Shareholders Significantly Increase Stakes in Tonner Drones: Confirmation of Confidence in Turnaround and Growth Strategy Paris, January 19, 2025, 08:00, Tonner Drones (’the Company’) is pleased to announce that two shareholders have notified the company that they have strengthened their shareholdings. Since the last update on November 14, 2025, two major shareholders have substantially expanded their holdings in the company through purchases on the open market. These announcements mark a significant development in Tonner Drones’ capital structure, with two shareholders doubling their stakes:Shareholder 1: Has doubled its position from 10 million shares to 20 million shares currently. Shareholder 2: Has increased its stake from a previously reported more than 5% to more than 10% (62M shares) of the outstanding capital.Combined...

Continue reading

Sampo plc’s share buybacks 16 January 2026

Sampo plc, stock exchange release, 19 January 2026 at 8:30 am EET Sampo plc’s share buybacks 16 January 2026 On 16 January 2026, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  6,006 9.99 AQEU    119,935 10.00 CEUX  40,173 9.99 TQEX  110,646 10.00 XHELTOTAL 276,760 10.00  * rounded to two decimals                      On 5 November 2025, Sampo announced a share buyback programme of up to a maximum of EUR 150 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 6 November...

Continue reading

Bagoe Update

Perth, Jan. 19, 2026 (GLOBE NEWSWIRE) — BAGOÉ ACCIDENT UPDATE Perth, Western Australia/January 19, 2026/Perseus Mining Limited (ASX/TSX: PRU) regrets to advise that, following the announcement of a fatal offsite vehicle accident that occurred last Thursday January 15 near our Bagoé Gold Mine in Côte d’Ivoire, another occupant in that vehicle, also an employee of our contractor company Binkadi, who was receiving care in hospital, has passed away. The other passengers in the vehicle sustained minor injuries and have been released from hospital. We extend our deepest sympathies to Mr Vakaramoko Sangare’s family. Both Perseus and Binkadi are providing support to the family through this very difficult time. Perseus is also offering support to our entire team at the Sissingué complex as they come to terms with this tragic event. Perseus...

Continue reading

Net asset value of the EfTEN United Property Fund as of 31.12.2025

For the first time in history, EfTEN United Property Fund’s financial results in 2025 were based on a fully invested portfolio. The fund achieved historically highest profit, which increased by 2.2 times compared to 2024: EfTEN United Property Fund earned 3.57 million euros in net profit in 2025 (1.62 million euros in 2024), which constitutes 14% of the fund’s invested capital and approximately 17% of the fund’s market capitalization. The fund’s income increased from 1.82 million euros to 3.78 million euros in a year, and the fund’s distributions to investors exceeded 9% of the market capitalization in 2025. The fund’s results were supported primarily by the improved profitability of the Uus-Järveküla residential development and the investment to the Kristiine shopping centre, where the fund is invested through...

Continue reading

Private Equity Expert Speed Liu Joins FTI Consulting in Hong Kong

HONG KONG, Jan. 18, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Speed Liu as a Senior Managing Director in the Business Transformation practice in Asia within the firm’s Corporate Finance & Restructuring segment. Mr. Liu, who is based in Hong Kong, joins FTI Consulting with more than 20 years of experience in private equity driving growth strategies, turnaround plans and cost optimization initiatives. He has substantial expertise advising on buyout transactions, business transformation and transactions across the consumer, service and industrials sectors. In his role at FTI Consulting, Mr. Liu will support private equity and corporate clients in Asia and abroad with portfolio transformation, transactions, exit readiness and maximizing value creation. His appointment reinforces...

Continue reading

FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy

Approval Label May Include Opioid Reduction NEW YORK, Jan. 18, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided feedback received from the U.S. Food & Drug Administration (FDA) on potential filing of a Biologics License Application (BLA) for its allogeneic cell therapy product rexlemestrocel-L in patients with chronic discogenic low back pain (CLBP). This follows FDA’s Type B meeting review of data from Mesoblast’s first randomized controlled Phase 3 trial (MSB-DR003) on pain reduction and relationship to decreased use or elimination of opioids for up to three years following a single rexlemestrocel-L administration. Mesoblast is seeking FDA approval for rexlemestrocel-L based on reduction in CLBP through 12 months....

Continue reading

Lotus Tech Responds to Canada’s New Tariff Policy, Positive for Eletre Model in the Country

Canada slashes 100% tariffs on Chinese EVs to 6.1%, directly benefiting Lotus Technology Inc. (NASDAQ: LOT)—the only mobility provider with Chinese-made EV entering the North American market above the $80,000 price segment. Under the new policy, the planned retail price of the Eletre in Canada is expected to be revised down approximately 50%, with wholesale deliveries projected to achieve exponential growth. Leveraging its North American homologation completed in 2024 and well-established retail network of authorized dealers in Canada, Lotus Tech is well-positioned to capitalize on this market opportunity.NEW YORK, Jan. 17, 2026 (GLOBE NEWSWIRE) — Lotus Technology Inc. (“Lotus Tech” or the “Company”) (Nasdaq: LOT), a leading global intelligent and luxury mobility provider has expressed significant attention and a warm welcome...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.